Glipizide Tablet
Product Images NDC 50268-362

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 50268-362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5 (361 15 5mg)

Glipizide Tablets USP 5 mg oral tablet label displaying product name, strength, and quantity (50 tablets, unit dose packaging). The label includes the NDC 50268-361-15, manufacturer AvPAK with location in Pulaski, TN, storage instructions at controlled room temperature, and Rx only status. Barcode is also visible on the label.*

FDA Label Image

10 (362 15 10mg)

GlipiZIDE Tablets, USP 10 mg oral tablets packaging label showing unit dose packaging of 50 tablets (5 x 10). The label states Rx only and indicates manufacturing by AvPAK for AvKARE, Pulaski, TN. Storage instructions and dosage reference to the package insert are included.*

FDA Label Image

Glipizide-structure.jpg (Glipizide Structure)

Chemical structure of Glipizide showing its molecular components, including a methyl-substituted nitrogen ring, sulfonylurea group attached to a benzene ring, and a cyclohexyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.